Earth Science Tech (ETST) Free Cash Flow Growth (3y) (2014 - 2026)
Earth Science Tech (ETST) Free Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 39.19% |
| 10 | Earth Science Tech | 33.70 Mn | 31.55 Mn | 6.27 Mn | 61.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.67% |
| Dec 31, 2025 | 16.46% |
| Sep 30, 2025 | 57.16% |
| Jun 30, 2025 | -44.00% |
| Mar 31, 2025 | 161.75% |
| Dec 31, 2024 | 113.58% |
| Sep 30, 2024 | 289.99% |
| Jun 30, 2024 | 195.27% |
| Mar 31, 2024 | 188.45% |
| Dec 31, 2023 | 68.65% |
| Sep 30, 2023 | 78.23% |
| Jun 30, 2023 | -8.52% |
| Mar 31, 2023 | -101.24% |
| Dec 31, 2022 | -47.41% |
| Sep 30, 2022 | -40.39% |
| Jun 30, 2022 | 54.62% |
| Mar 31, 2022 | 22.79% |
| Dec 31, 2021 | 64.63% |
| Sep 30, 2021 | 26.54% |
| Jun 30, 2021 | 52.50% |